Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database - Morice, Pierre‐Marie; Léary, Alexandra; Dolladille, Charles; Chrétien, Basile; Poulain, Laurent; González-Martı́n, Antonio; Moore, Kathleen N.; O’Reilly, Eileen M.; Ray‐Coquard, Isabelle; Alexandre, Joachim (The Lancet Haematology, 2020)